Kenvue INC Form 4 insider transactions

Kenvue Inc.'s CEO, Kirk Perry, was granted 491,662 Restricted Stock Units, vesting over three years.

Kenvue's Chief Scientific Officer, Caroline Tillett, was granted 63,525 Restricted Stock Units, aligning her interests with long-term shareholder value.

Kenvue Inc.'s Chief Operations Officer, Meredith Stevens, was granted 92,641 Restricted Stock Units, vesting over three years.

Kenvue's Chief Digital & Marketing Officer, Jonathan Halvorson, was granted 51,879 Restricted Stock Units, vesting over three years.

Kenvue's Chief Corporate Affairs Officer, Russell Dyer, was granted 43,673 Restricted Stock Units, vesting over three years.

Kenvue's Chief Operations Officer, Meredith Stevens, reported the vesting of Restricted Stock Units and subsequent share dispositions for tax purposes.

Kenvue's Chief People Officer, Luani Alvarado, reported the vesting of Restricted Stock Units and subsequent tax-related share dispositions, effective February 13, 2026.

Kenvue Group President Carlton Lawson acquired 39,426 shares of common stock through the vesting of restricted stock units.

Kenvue's VP & Chief Accounting Officer, Heather Howlett, reported the vesting of restricted stock units and subsequent tax-related share disposals.

Kenvue's Chief People Officer, Luani Alvarado, exercised expiring stock options and had shares withheld for tax obligations.

Kimberly-Clark delivered robust Q4 and full-year 2025 results, driven by its 'Powering Care' strategy, and remains confident in its pending Kenvue acquisition to create a global health and wellness leader.

Kimberly-Clark Corporation has filed supplemental disclosures for its Kenvue merger proxy statement to address multiple stockholder lawsuits alleging material omissions and misstatements.

Kenvue Inc. has filed a supplement to its joint proxy statement/prospectus for the proposed merger with Kimberly-Clark Corporation, addressing shareholder litigation and providing updated financial analysis details.

Kimberly-Clark and Kenvue have filed definitive proxy statements and prospectuses with the SEC regarding their proposed transaction, seeking stockholder approval.

Kenvue Inc. and Kimberly-Clark Corporation announce the effectiveness of their joint proxy statement/prospectus for a proposed transaction, urging stockholders to review important information.

Kimberly-Clark Corporation filed a Rule 425 document, including website screenshots, related to its proposed transaction with Kenvue Inc.

Kenvue Inc. has provided employees with details regarding the anticipated impact of its transaction with Kimberly-Clark on compensation, benefits, and equity.

Kimberly-Clark Corporation announces its proposed acquisition of Kenvue Inc., aiming to create a global health and wellness leader through a complementary portfolio of trusted brands and significant synergies.

Kimberly-Clark and Kenvue provide an update on their proposed transaction, including details on proxy solicitation and important investor information.

Kenvue's Chief Financial Officer, Amit Banati, was granted 144,341 Restricted Stock Units, vesting over three years.

Kenvue Inc.'s Chief Digital & Marketing Officer, Jonathan Halvorson, was granted 34,642 Restricted Stock Units, vesting over three years.

Kenvue Inc.'s CEO, Kirk Perry, filed an amended Form 4 to correct an administrative error in shares withheld for taxes related to vested Restricted Stock Units.

Kenvue's Group President North America, Carlos De Jesus, was granted 50,842 Restricted Stock Units and 483,870 Stock Options, vesting over three years.

Kenvue's Chief Corporate Affairs Officer, Russell Dyer, had RSU vesting accelerated on December 15, 2025, citing a pending transaction with Kimberly-Clark Corporation.

Kenvue CEO Kirk Perry reported accelerated vesting of Restricted Stock Units and subsequent tax-related share sales, driven by a pending transaction with Kimberly-Clark Corporation.

Kenvue Group President APAC, Anindya Dasgupta, filed an amended Form 4 to correct an inadvertent omission of 32,649 Restricted Stock Units.

Kenvue's Chief Scientific Officer, Caroline Tillett, accelerated the vesting of restricted stock units totaling 33,922.64 shares, primarily to mitigate Section 280G tax impacts related to a pending transaction with Kimberly-Clark Corporation.

Kenvue's General Counsel, Matthew Orlando, reported accelerated vesting of restricted stock units and subsequent tax-related share dispositions, linked to a pending transaction with Kimberly-Clark Corporation.

Kenvue Director Jeffrey C. Smith, through Starboard Value LP, acquired over 6.3 million shares of Kenvue common stock in two transactions in December 2025.

Kimberly-Clark and Kenvue filed a preliminary joint proxy statement/prospectus with the SEC for their proposed transaction, seeking stockholder approval.